Back to results
CompletedPhase 1

Low Dose IL2 Immunotherapy in AD

NCT05821153

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Alireza Faridar

Houston, Texas, United States

View on ClinicalTrials.gov
Low Dose IL2 Immunotherapy in AD — TrialFind